A clinical trial of once-weekly TZT in T2DM patients illustrated that at 26 weeks of treatment, TZT led to the significant reduction of intercellular adhesion molecule 1 (ICAM-1), growth differentiation factor 15 (GDF-15), chitosan-3 like protein 1 (YKL-40), leptin and CRP compared to the baseline values
Intravenous (IV): 5002000mg per infusion, weekly or biweekly
Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Hooper L, Kiesswetter E, et al
cDNA was synthesized with the iScript cDNA Synthesis Kit (#170-8891, Biorad) and subjected to quantitative real-time PCR using SYBR Green Supermix (#172-5272, Biorad)
It is important to choose a reputable brand and consult with a healthcare provider before starting any supplement regimen
Multiple measures of cardiometabolic risk improved, including blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, total and low-density lipoprotein cholesterol, and triglycerides